Study Title: Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
- Closed to Accrual at:
- University of Illinois Cancer Center
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
- Michigan State University Breslin Cancer Center
- Masonic Cancer Center, University of Minnesota
- Penn State Cancer Institute
- Rutgers Cancer Institute of New Jersey
- Fred & Pamela Buffett Cancer Center (University of Nebraska)
- University of Wisconsin Carbone Cancer Center
- Barbara Ann Karmanos Cancer Center
- Rush University Cancer Center
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- University of Louisville James Graham Brown Cancer Center
- Learn more:
- Publications and Presentations:
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube